Literature DB >> 18830896

Elevated plasma adiponectin and decreased plasma homocysteine and asymmetric dimethylarginine in children with type 1 diabetes.

Kaire Heilman1, Mihkel Zilmer, Kersti Zilmer, Pille Kool, Vallo Tillmann.   

Abstract

OBJECTIVE: Type 1 diabetes has a bad prognosis concerning the pathogenesis of cardiovascular diseases (CVD). The purpose of this study was to evaluate different possible new risk indices for CVD in children with type 1 diabetes.
MATERIAL AND METHODS: The present study included 30 children with diabetes (mean HbA1C 9.8%), aged between 4.7 and 18.6 years and with no clinical evidence of vascular complications, and 30 healthy subjects matched by sex, age and body mass index. Blood pressure was measured and blood samples were obtained for lipid profile, creatinine, glucose, high sensitive C-reactive protein (hsCRP), intercellular adhesion molecule-1 (ICAM-1), asymmetric dimethylarginine (ADMA), adiponectin and homocysteine.
RESULTS: Children with diabetes had significantly higher blood pressure, plasma hsCRP, ICAM-1, adiponectin levels and lower homocysteine, ADMA concentrations than their control subjects. In multivariate regression analysis, the best predictors for systolic blood pressure were diabetes group, plasma homocysteine concentration and BMI (Adj R(2) = 0.38, p<0.0001), and for diastolic blood pressure diabetes group and triglycerides level (Adj R(2) = 0.27, p<0.0001).
CONCLUSIONS: Children with diabetes, in view of their higher future risk of CVD, are characterized by a higher concentration of protective adiponectin and paradoxically lower blood concentrations of some other possible risk markers of atherosclerosis, i.e. ADMA and homocysteine compared to healthy children.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18830896     DOI: 10.1080/00365510802419454

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  12 in total

Review 1.  Adiponectin: Probe of the molecular paradigm associating diabetes and obesity.

Authors:  Kakali Ghoshal; Maitree Bhattacharyya
Journal:  World J Diabetes       Date:  2015-02-15

2.  Association of plasma soluble E-selectin and adiponectin with carotid plaque in patients with systemic lupus erythematosus.

Authors:  Harmony R Reynolds; Jill Buyon; Mimi Kim; Tania L Rivera; Peter Izmirly; Paul Tunick; Robert M Clancy
Journal:  Atherosclerosis       Date:  2009-12-16       Impact factor: 5.162

3.  Association of homocysteine with type 1 diabetes mellitus: a meta-analysis.

Authors:  Yu Feng; Mei-Qin Shan; Lin Bo; Xiao-Yan Zhang; Ji Hu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  Circulating endothelial progenitor cells and large artery structure and function in young subjects with uncomplicated type 1 diabetes.

Authors:  Carlo Palombo; Michaela Kozakova; Carmela Morizzo; Laura Gnesi; Maria Chiara Barsotti; Paolo Spontoni; Francesco Massart; Paolo Salvi; Alberto Balbarini; Giuseppe Saggese; Rossella Di Stefano; Giovanni Federico
Journal:  Cardiovasc Diabetol       Date:  2011-10-08       Impact factor: 9.951

5.  Increased carotid artery intima-media thickness and myeloperoxidase level in children with newly diagnosed juvenile idiopathic arthritis.

Authors:  Jaanika Ilisson; Maksim Zagura; Kersti Zilmer; Erik Salum; Kaire Heilman; Anneli Piir; Vallo Tillmann; Jaak Kals; Mihkel Zilmer; Chris Pruunsild
Journal:  Arthritis Res Ther       Date:  2015-07-16       Impact factor: 5.156

6.  The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes.

Authors:  Trevor J Orchard; Bertrand Cariou; Margery A Connelly; James D Otvos; Shuyu Zhang; Caryl J Antalis; Tibor Ivanyi; Byron J Hoogwerf
Journal:  Cardiovasc Diabetol       Date:  2017-06-06       Impact factor: 9.951

7.  Associations between endogenous dimethylarginines and renal function in healthy children and adolescents.

Authors:  Aleksandra Jaźwińska-Kozuba; Jens Martens-Lobenhoffer; Andrzej Surdacki; Olga Kruszelnicka; Jarosław Rycaj; Urszula Godula-Stuglik; Stefanie M Bode-Böger
Journal:  Int J Mol Sci       Date:  2012-11-21       Impact factor: 5.923

Review 8.  Asymmetric dimethylarginine, endothelial dysfunction and renal disease.

Authors:  Luis Aldámiz-Echevarría; Fernando Andrade
Journal:  Int J Mol Sci       Date:  2012-09-10       Impact factor: 6.208

9.  A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria.

Authors:  Latika Sibal; Sharad C Agarwal; Edzard Schwedhelm; Nicole Lüneburg; Rainer H Böger; Philip D Home
Journal:  Cardiovasc Diabetol       Date:  2009-06-01       Impact factor: 9.951

10.  Longitudinal Analysis of Adiponectin through 20-Year Type 1 Diabetes Duration.

Authors:  Tamara J LeCaire; Mari Palta
Journal:  J Diabetes Res       Date:  2015-04-09       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.